PL375603A1 - Depot formulations of arylheterocyclic active agents in the form of a suspension - Google Patents

Depot formulations of arylheterocyclic active agents in the form of a suspension

Info

Publication number: PL375603A1
Authority: PL; Poland
Prior art keywords: arylheterocyclic; suspension; active agents; depot formulations; depot
Prior art date: 2002-10-25

Application number

PL03375603A

Other languages

English (en)

Polish (pl)

Inventor

Jaymin Chandrakant Shah

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-25

Filing date

2003-10-13

Publication date

2005-12-12

2003-10-13 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2005-12-12 Publication of PL375603A1 publication Critical patent/PL375603A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PL03375603A 2002-10-25 2003-10-13 Depot formulations of arylheterocyclic active agents in the form of a suspension PL375603A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US42129502P	2002-10-25	2002-10-25

Publications (1)

Publication Number	Publication Date
PL375603A1 true PL375603A1 (en)	2005-12-12

Family

ID=32176696

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL03375603A PL375603A1 (en)	2002-10-25	2003-10-13	Depot formulations of arylheterocyclic active agents in the form of a suspension

Country Status (21)

Country	Link
US (1)	US20040146562A1 (xx)
EP (1)	EP1562546A1 (xx)
JP (2)	JP2006505579A (xx)
KR (1)	KR20050071611A (xx)
CN (1)	CN1703198A (xx)
AR (1)	AR041826A1 (xx)
AU (1)	AU2003267763A1 (xx)
BR (1)	BR0315663A (xx)
CA (1)	CA2498276A1 (xx)
GT (1)	GT200300227A (xx)
MX (1)	MXPA05004299A (xx)
NL (1)	NL1024616C (xx)
NO (1)	NO20051187L (xx)
PA (1)	PA8586301A1 (xx)
PE (1)	PE20040471A1 (xx)
PL (1)	PL375603A1 (xx)
RU (1)	RU2292207C2 (xx)
TW (1)	TW200418477A (xx)
UY (1)	UY28035A1 (xx)
WO (1)	WO2004037224A1 (xx)
ZA (1)	ZA200501979B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080113025A1 (en) *	1998-11-02	2008-05-15	Elan Pharma International Limited	Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
US20040001889A1 (en)	2002-06-25	2004-01-01	Guohua Chen	Short duration depot formulations
HRP20050149B1 (hr)	2002-08-20	2014-09-12	Otsuka Pharmaceutical Co., Ltd.	Formulacija aripiprazol kompleksa i postupak
CN101797221B (zh)	2002-12-13	2013-06-12	杜雷科特公司	包含高粘度液体载体材料的口服递药系统
MXPA05012392A (es) *	2003-05-16	2006-02-02	Pfizer Prod Inc	Tratamientos de ansiedad con ziprasidona.
WO2006000913A1 (en) *	2004-06-23	2006-01-05	Pfizer Products Inc.	Method for sterile filtration of viscous pharmaceutical compositions
HUE032040T2 (en) *	2004-09-17	2017-09-28	Durect Corp	Saib-containing (sucrose acetate-isobutyrate) sustained-release local anesthetic composition
US20080254114A1 (en) *	2005-03-03	2008-10-16	Elan Corporation Plc	Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
US20070027105A1 (en)	2005-07-26	2007-02-01	Alza Corporation	Peroxide removal from drug delivery vehicle
CN100391458C (zh) *	2006-02-07	2008-06-04	上海医药工业研究院	齐拉西酮或其盐包合物制备方法
EP2018151A4 (en) *	2006-05-09	2012-07-18	Astrazeneca Ab	STERILIZED PARENTERAL FORMULATION WITH PROTONED PUMP INHIBITOR BY IONIZING RADIATION IN THE END TANK
US8337883B2 (en)	2006-11-03	2012-12-25	Durect Corporation	Transdermal delivery systems
AU2008335809A1 (en) *	2007-12-06	2009-06-18	Durect Corporation	Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en)	2008-11-03	2010-10-14	Scicinski Jan J	Oral pharmaceutical dosage forms
WO2014144975A1 (en)	2013-03-15	2014-09-18	Durect Corporation	Compositions with a rheological modifier to reduce dissolution variability
CA3028450A1 (en)	2016-07-06	2018-01-11	Durect Corporation	Oral dosage form with drug composition, barrier layer and drug layer
WO2018153315A1 (zh) *	2017-02-23	2018-08-30	上海华汇拓医药科技有限公司	一种多奈哌齐半帕莫酸盐的粉针剂、包含其的组合物及它们的制备方法
WO2021146215A1 (en)	2020-01-13	2021-07-22	Durect Corporation	Sustained release drug delivery systems with reduced impurities and related methods
JP2024503402A (ja)	2021-01-12	2024-01-25	デュレクトコーポレーション	徐放性薬物送達システム及び関連の方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1989002265A1 (fr) *	1987-09-07	1989-03-23	Teijin Limited	Emulsion grasse contenant un medicament, du type prepare immediatement avant l'utilisation, et procede de preparation d'une telle emulsion grasse contenant un medicament
GB9200247D0 (en) *	1992-01-07	1992-02-26	Erba Carlo Spa	Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
JP3954115B2 (ja) *	1992-07-28	2007-08-08	アストラゼネカ・アクチエボラーグ	注射剤および注射剤キット
US5594141A (en) *	1994-11-23	1997-01-14	Neurogen Corporation	Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands
US6040295A (en) *	1995-01-13	2000-03-21	Genemedicine, Inc.	Formulated nucleic acid compositions and methods of administering the same for gene therapy
EP0811386B1 (en) *	1996-05-07	2004-09-29	Pfizer Inc.	Method of selecting a salt for making an inclusion complex
UA57734C2 (uk) *	1996-05-07	2003-07-15	Пфайзер Інк.	Комплекси включення арилгетероциклічних солей
WO1998027962A2 (en) *	1996-12-20	1998-07-02	Alza Corporation	Injectable depot gel composition and method of preparing the composition
YU58599A (sh) *	1997-05-16	2000-12-28	Amgen Inc.	Gelovi sa usporenim podržanim oslobađanjem
UA72189C2 (uk) *	1997-11-17	2005-02-15	Янссен Фармацевтика Н.В.	Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
EA003907B1 (ru) *	1999-05-27	2003-10-30	Пфайзер Продактс Инк.	Композиция зипразидона в виде суспензии
MY137726A (en) *	2000-11-22	2009-03-31	Nycomed Gmbh	Freeze-dried pantoprazole preparation and pantoprazole injection
JP4334229B2 (ja) *	2001-03-20	2009-09-30	サイデックス・ファーマシューティカルズ・インコーポレイテッド	プロポフォール及びスルホアルキルエーテルシクロデキストリン含有製剤
EP1269994A3 (en) *	2001-06-22	2003-02-12	Pfizer Products Inc.	Pharmaceutical compositions comprising drug and concentration-enhancing polymers
CA2458968A1 (en) *	2001-08-31	2003-03-13	The Rockefeller University	Method for classification of anti-psychotic drugs

2003
- 2003-10-13 JP JP2004546259A patent/JP2006505579A/ja active Pending
- 2003-10-13 WO PCT/IB2003/004535 patent/WO2004037224A1/en not_active Ceased
- 2003-10-13 EP EP03748458A patent/EP1562546A1/en not_active Withdrawn
- 2003-10-13 CA CA002498276A patent/CA2498276A1/en not_active Abandoned
- 2003-10-13 PL PL03375603A patent/PL375603A1/xx not_active Application Discontinuation
- 2003-10-13 MX MXPA05004299A patent/MXPA05004299A/es unknown
- 2003-10-13 BR BR0315663-0A patent/BR0315663A/pt not_active IP Right Cessation
- 2003-10-13 RU RU2005112202/15A patent/RU2292207C2/ru not_active IP Right Cessation
- 2003-10-13 CN CNA2003801011573A patent/CN1703198A/zh active Pending
- 2003-10-13 AU AU2003267763A patent/AU2003267763A1/en not_active Abandoned
- 2003-10-13 KR KR1020057006963A patent/KR20050071611A/ko not_active Ceased
- 2003-10-14 PA PA20038586301A patent/PA8586301A1/es unknown
- 2003-10-21 US US10/689,778 patent/US20040146562A1/en not_active Abandoned
- 2003-10-21 PE PE2003001065A patent/PE20040471A1/es not_active Application Discontinuation
- 2003-10-21 GT GT200300227A patent/GT200300227A/es unknown
- 2003-10-22 UY UY28035A patent/UY28035A1/es not_active Application Discontinuation
- 2003-10-23 AR ARP030103869A patent/AR041826A1/es unknown
- 2003-10-24 TW TW092129567A patent/TW200418477A/zh unknown
- 2003-10-24 NL NL1024616A patent/NL1024616C/nl not_active IP Right Cessation
2005
- 2005-03-04 NO NO20051187A patent/NO20051187L/no not_active Application Discontinuation
- 2005-04-08 ZA ZA200501979A patent/ZA200501979B/en unknown
2006
- 2006-05-23 JP JP2006142886A patent/JP2006219501A/ja active Pending

Also Published As

Publication number	Publication date
GT200300227A (es)	2004-06-23
PA8586301A1 (es)	2004-05-07
NL1024616C (nl)	2010-04-19
MXPA05004299A (es)	2005-08-03
KR20050071611A (ko)	2005-07-07
ZA200501979B (en)	2006-04-26
PE20040471A1 (es)	2004-08-14
UY28035A1 (es)	2004-05-31
US20040146562A1 (en)	2004-07-29
NL1024616A1 (nl)	2004-04-27
JP2006505579A (ja)	2006-02-16
RU2292207C2 (ru)	2007-01-27
AU2003267763A1 (en)	2004-05-13
RU2005112202A (ru)	2005-11-20
NO20051187L (no)	2005-04-11
TW200418477A (en)	2004-10-01
EP1562546A1 (en)	2005-08-17
CN1703198A (zh)	2005-11-30
WO2004037224A1 (en)	2004-05-06
CA2498276A1 (en)	2004-05-06
AR041826A1 (es)	2005-06-01
BR0315663A (pt)	2005-08-30
JP2006219501A (ja)	2006-08-24

Publication	Publication Date	Title
PL375603A1 (en)	2005-12-12	Depot formulations of arylheterocyclic active agents in the form of a suspension
PL370501A1 (en)	2005-05-30	Cyclosporine analogue mixtures and their use as immunomodulating agents
GB0028161D0 (en)	2001-01-03	Personal care compositions
EP1313470A4 (en)	2005-02-16	NEW ALICYCLIC IMIDAZOLE AS H 3 ACTIVE SUBSTANCES
AU2003298738A8 (en)	2004-06-18	Liposomal formulations
IL152514A0 (en)	2003-05-29	Fungicidal combinations of active agents
AU2003285346A8 (en)	2004-06-30	Regulatory elements in the 5' region of the vr1 gene
AU2003298083A1 (en)	2004-05-13	Detergent in the form of mould elastic body
AU2003302320A8 (en)	2004-06-23	Seterocyclic quinones as pharmaceutical agents
GB2388100B (en)	2004-12-15	"Pallets"
AU2002361181A8 (en)	2003-07-15	Shaped body containing agents with increased storage stability
GB0214147D0 (en)	2002-07-31	Formulations
PH12003501081B1 (en)	2009-11-05	Insecticidal composition having improved storage stability
GB0103354D0 (en)	2001-03-28	Biologically active agents
GB0208752D0 (en)	2002-05-29	The soak n' soap
AU143729S (en)	2001-05-03	Spray caddy
AU148305S (en)	2002-07-01	Spray caddy
GB0010760D0 (en)	2000-06-28	Top of the class-board game
ZA200304306B (en)	2004-04-23	"Provision of graphic designs".
GB0115562D0 (en)	2001-08-15	None given on form 1/77
GB0228029D0 (en)	2003-01-08	The "wand"
PL352618A1 (en)	2003-09-08	Jewelller's stone
GB0201314D0 (en)	2002-03-06	Dice 100 game
TW419959U (en)	2001-01-21	Structure of the shoe model head with elasticity
GB0127289D0 (en)	2002-01-02	2 in 1 flask

Legal Events

Date	Code	Title	Description
2010-07-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)